Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 266 articles: HTML format Text format

Single Articles

June 2018
1. LEE DH, Ahn JH, Chung JW, Kim YJ, et al
   Varices on CT is Surrogate of Clinically Significant Portal Hypertension and can Predict Survival in Compensated Cirrhosis Patients.
   J Gastroenterol Hepatol. 2018 Jun 14. doi: 10.1111/jgh.14319.
   PubMed     Text format     Abstract available
   
   
   
2. KAWAKAMI Y, Suzuki K, Miyake T, Hayashi Y, et al
   Hepatobiliary and Pancreatic: Hepatic alveolar echinococcosis mimics cholangiocarcinoma: Role of EUS-FNA.
   J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14279.
   PubMed     Text format    
   
   
   
3. WANG YF, Chen HQ
   Hepatobiliary and Pancreatic: Spontaneous cholecystocutaneous fistula.
   J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14285.
   PubMed     Text format    
   
   
   
4. LUO Q, Pang Z, Liu C, Liu X, et al
   Hepatobiliary and Pancreatic: Spontaneous hepatic hemorrhage caused by Ehlers-Danlos syndrome.
   J Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1111/jgh.14278.
   PubMed     Text format    
   
   
   
5. HONG J, Wang K, Yu Y
   Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor.
   J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14272.
   PubMed     Text format    
   
   
   
6. YAMASHIMA M, Ozawa E, Ohnita K, Tabata K, et al
   Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
   J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14274.
   PubMed     Text format    
   
   
   
7. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
   Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
   J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
   PubMed     Text format     Abstract available
   
   
   
8. LIU T, Xu L, Wang C, Chen K, et al
   Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
   J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
   PubMed     Text format     Abstract available
   
   
   
9. DONG XQ, Li J, Liu H, Wang YW, et al
   Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
   J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
   PubMed     Text format    
   
   
   
10. LIN YX, Fu YY, Cui T, Jia QB, et al
    Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
    J Gastroenterol Hepatol. 2018;33:1167.
    PubMed     Text format    
    
    
    
11. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
    Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
    J Gastroenterol Hepatol. 2018;33:1166.
    PubMed     Text format    
    
    
    May 2018
12. AZUMA S, Kurita A, Yazumi S
    Hepatobiliary and Pancreatic: Burkitt lymphoma mimicking IgG4-related disease.
    J Gastroenterol Hepatol. 2018 May 28. doi: 10.1111/jgh.14276.
    PubMed     Text format    
    
    
    
13. KANG MK, Goo EJ, Kim SB, Kim KH, et al
    Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with distant cutaneous metastases to the face.
    J Gastroenterol Hepatol. 2018 May 16. doi: 10.1111/jgh.14091.
    PubMed     Text format    
    
    
    
14. KATO S, Kuwatani M, Kawakubo K, Sugiura R, et al
    Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis.
    J Gastroenterol Hepatol. 2018 May 15. doi: 10.1111/jgh.14088.
    PubMed     Text format    
    
    
    
15. YASUDA S, Ishigami M, Ishizu Y, Kuzuya T, et al
    Substitutions in interferon sensitivity determining region and hepatocarcinogenesis after hepatitis C virus eradication.
    J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14280.
    PubMed     Text format     Abstract available
    
    
    
16. UOJIMA H, Hidaka H, Tanaka Y, Inoue T, et al
    Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14277.
    PubMed     Text format     Abstract available
    
    
    
17. MANATSATHIT W, Samant H, Kapur S, Ingviya T, et al
    Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score, in detection of esophageal varices: systemic review and meta-analysis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14271.
    PubMed     Text format     Abstract available
    
    
    
18. KOBAYASHI M, Ryozawa S, Nagata K
    Hepatobiliary and Pancreatic: A case of pure squamous cell carcinoma of the gallbladder.
    J Gastroenterol Hepatol. 2018;33:976.
    PubMed     Text format    
    
    
    
19. LAINO ME, Ragucci M, Klimstra DS, Mannelli L, et al
    Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy.
    J Gastroenterol Hepatol. 2018;33:977.
    PubMed     Text format    
    
    
    
20. KAMIJO Y
    Is hepatic peroxisome proliferator-activated receptor alpha essential for the metabolic effects of fibrates?
    J Gastroenterol Hepatol. 2018;33:978-979.
    PubMed     Text format    
    
    
    April 2018
21. HAMOIR C, de Vos M, Clinckart F, Nicaise G, et al
    Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.
    J Gastroenterol Hepatol. 2018 Apr 29. doi: 10.1111/jgh.14136.
    PubMed     Text format    
    
    
    
22. HABIB S, Patel N, Yarlagadda S, Hsu CH, et al
    Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14267.
    PubMed     Text format     Abstract available
    
    
    
23. SHIRAISHI Y, Imai K, Yamashita YI, Nakao Y, et al
    Hepatobiliary and Pancreatic: Segmental arterial mediolysis of pancreaticoduodenal artery accompanied by acute pancreatitis and duodenal obstruction.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14138.
    PubMed     Text format    
    
    
    
24. ZHANG L, Gao H, Feng Y, Wang G, et al
    Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14084.
    PubMed     Text format    
    
    
    
25. CATERSON H, Liu K
    Hepatobiliary and Pancreatic: Rare hepatic vascular tumor presenting with hypertrophic osteoarthropathy.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14087.
    PubMed     Text format    
    
    
    
26. SESHACHALAM VP, Sekar K, Hui KM
    Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    J Gastroenterol Hepatol. 2018 Apr 19. doi: 10.1111/jgh.14262.
    PubMed     Text format     Abstract available
    
    
    
27. NIMRI L, Staikin K, Peri I, Yehuda-Shnaidman E, et al
    Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis.
    J Gastroenterol Hepatol. 2018 Apr 16. doi: 10.1111/jgh.14259.
    PubMed     Text format     Abstract available
    
    
    
28. KODAMA K, Kawaoka T, Aikata H, Uchikawa S, et al
    Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    J Gastroenterol Hepatol. 2018 Apr 12. doi: 10.1111/jgh.14152.
    PubMed     Text format     Abstract available
    
    
    
29. LIN YX, Hu HJ, Li FY, Jia QB, et al
    Hepatobiliary and Pancreatic: Biliary reoperation for recurrent intrahepatic stones in patients with polysplenia syndrome.
    J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14137.
    PubMed     Text format    
    
    
    
30. YANG MJ, Kim JH, Kim DJ, Hwang JC, et al
    Hepatobiliary and Pancreatic: EUS-guided reintervention for extraluminal stent migration after EUS-guided hepaticogastrostomy.
    J Gastroenterol Hepatol. 2018;33:772.
    PubMed     Text format    
    
    
    
31. KANG MK, Kim TN
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma diagnosed by proptosis due to metastatic orbital mass.
    J Gastroenterol Hepatol. 2018;33:773.
    PubMed     Text format    
    
    
    March 2018
32. CHAN WK, Mustapha NRN, Mahadeva S, Wong VW, et al
    Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14150.
    PubMed     Text format     Abstract available
    
    
    
33. TANDON P, Bishay K, Fisher S, Yelle D, et al
    Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
    PubMed     Text format     Abstract available
    
    
    
34. PARK SW, Jun CH, Choi SK, Kim HJ, et al
    Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
    J Gastroenterol Hepatol. 2018;33:562.
    PubMed     Text format    
    
    
    
35. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
    Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
    J Gastroenterol Hepatol. 2018;33:563.
    PubMed     Text format    
    
    
    February 2018
36. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    PubMed     Text format     Abstract available
    
    
    
37. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    PubMed     Text format     Abstract available
    
    
    
38. YAMADA T, Nakanishi Y, Okamura K, Tsuchikawa T, et al
    Impact of serum CA19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14124.
    PubMed     Text format     Abstract available
    
    
    
39. DOI H, Hayashi E, Arai J, Tojo M, et al
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
    PubMed     Text format     Abstract available
    
    
    
40. HACZEYNI F, Yeh MM, Ioannou GN, Leclercq IA, et al
    Mouse Models Of Nonalcoholic Steatohepatitis: A Reflection On Recent Literature.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14122.
    PubMed     Text format     Abstract available
    
    
    
41. OKUNO N, Hara K, Mizuno N, Kuwahara T, et al
    Efficacy of the 6-mm FCSEMS during EUS-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult ERCP: a prospective clinical study.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14112.
    PubMed     Text format     Abstract available
    
    
    
42. WANG Q, Wang G, Wang Y, Liu C, et al
    ALKBH3 expression is associated with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117.
    PubMed     Text format     Abstract available
    
    
    
43. ZHANG LH, Tai Y, Tong H, Lei XJ, et al
    Hepatobiliary and Pancreatic: Rare cause of obstructive jaundice by Trichosporon asahii.
    J Gastroenterol Hepatol. 2018;33:338.
    PubMed     Text format    
    
    
    
44. JAISWAL P, Jaiswal R, Attar BM, Dedania B, et al
    Hepatobiliary and Pancreatic: Massive hepatic cystic echinococcosis compressing inferior vena cava.
    J Gastroenterol Hepatol. 2018;33:339.
    PubMed     Text format    
    
    
    
45. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
    Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2018;33:511-517.
    PubMed     Text format     Abstract available
    
    
    
46. DUAN X, Meng Q, Wang C, Liu Z, et al
    Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    J Gastroenterol Hepatol. 2018;33:533-542.
    PubMed     Text format     Abstract available
    
    
    January 2018
47. MANCEBO A, Varela M, Gonzalez-Dieguez ML, Navascues CA, et al
    Incidence and Risk Factors Associated with Hepatocellular Carcinoma Surveillance Failure.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14108.
    PubMed     Text format     Abstract available
    
    
    
48. ZHANG F, Zhang J, Li X, Li B, et al
    The Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14110.
    PubMed     Text format     Abstract available
    
    
    
49. KAO JH, Yu ML, Chen CY, Peng CY, et al
    Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
    J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
    PubMed     Text format     Abstract available
    
    
    
50. KIM NH, Lee T, Cho YK, Kim BI, et al
    Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    J Gastroenterol Hepatol. 2018 Jan 3. doi: 10.1111/jgh.14083.
    PubMed     Text format     Abstract available
    
    
    
51. FANG X, Liu LW, Dong J, Zhang J, et al
    A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
    PubMed     Text format     Abstract available
    
    
    
52. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    PubMed     Text format    
    
    
    
53. CRIMI F, Guido M, Pomerri F
    Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
    J Gastroenterol Hepatol. 2018;33:8.
    PubMed     Text format    
    
    
    December 2017
54. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
    Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
    J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
    PubMed     Text format     Abstract available
    
    
    
55. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
    PubMed     Text format     Abstract available
    
    
    
56. ZHOU LY, Ma YJ, Tian F
    Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.
    J Gastroenterol Hepatol. 2017;32:1913.
    PubMed     Text format    
    
    
    
57. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    PubMed     Text format     Abstract available
    
    
    November 2017
58. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
    Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
    PubMed     Text format     Abstract available
    
    
    
59. LI G, Brocker CN, Xie C, Yan T, et al
    Hepatic PPARalpha mediates the major metabolic effects of Wy-14643.
    J Gastroenterol Hepatol. 2017 Nov 15. doi: 10.1111/jgh.14046.
    PubMed     Text format     Abstract available
    
    
    
60. SCHLEVOGT B, Rehkamper J, Hild B, Schmidt HH, et al
    Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.
    J Gastroenterol Hepatol. 2017;32:1795.
    PubMed     Text format    
    
    
    
61. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:1867-1872.
    PubMed     Text format     Abstract available
    
    
    
62. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
    Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
    J Gastroenterol Hepatol. 2017;32:1852-1858.
    PubMed     Text format     Abstract available
    
    
    October 2017
63. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
    Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
    J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
    PubMed     Text format     Abstract available
    
    
    
64. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
    Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
    J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
    PubMed     Text format     Abstract available
    
    
    
65. CHOE EY, Lee YH, Choi YJ, Huh BW, et al
    Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2017 Oct 8. doi: 10.1111/jgh.14011.
    PubMed     Text format     Abstract available
    
    
    
66. SHI SH, Feng XN, Wang ZY, Sun K, et al
    Pyogenic liver abscess related to intrahepatic bile duct stones: difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    J Gastroenterol Hepatol. 2017 Oct 6. doi: 10.1111/jgh.14010.
    PubMed     Text format     Abstract available
    
    
    
67. DING F, Li Q, Duan X, Ye J, et al
    Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
    J Gastroenterol Hepatol. 2017;32:1666.
    PubMed     Text format    
    
    
    
68. GILES H, Ross A, Gearry RB
    Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
    J Gastroenterol Hepatol. 2017;32:1663.
    PubMed     Text format    
    
    
    
69. NGUYEN BD
    Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    J Gastroenterol Hepatol. 2017;32:1667.
    PubMed     Text format    
    
    
    
70. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
    Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1668-1678.
    PubMed     Text format     Abstract available
    
    
    
71. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
    Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
    J Gastroenterol Hepatol. 2017;32:1746-1753.
    PubMed     Text format     Abstract available
    
    
    
72. LIN YJ, Gao XM, Pan WW, Gao S, et al
    A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
    J Gastroenterol Hepatol. 2017;32:1739-1745.
    PubMed     Text format     Abstract available
    
    
    September 2017
73. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
    J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
    PubMed     Text format     Abstract available
    
    
    
74. SEO YS, Park SY, Kim MY, Kim SG, et al
    Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
    J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
    PubMed     Text format     Abstract available
    
    
    
75. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
    Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
    J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
    PubMed     Text format     Abstract available
    
    
    
76. ESO Y, Takai A, Arasawa S, Ueda Y, et al
    Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guerin disease.
    J Gastroenterol Hepatol. 2017;32:1538.
    PubMed     Text format    
    
    
    
77. LIU PC, Wu MS, Hsieh MC, Suk FM, et al
    Hepatobiliary and Pancreatic: Development from gallbladder stone to gallstone ileus.
    J Gastroenterol Hepatol. 2017;32:1539.
    PubMed     Text format    
    
    
    
78. LV XH, Wang CH, Xie Y
    Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1540-1547.
    PubMed     Text format     Abstract available
    
    
    
79. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
    Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    J Gastroenterol Hepatol. 2017;32:1617-1623.
    PubMed     Text format     Abstract available
    
    
    
80. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
    Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
    J Gastroenterol Hepatol. 2017;32:1587-1597.
    PubMed     Text format     Abstract available
    
    
    August 2017
81. GERAGE AM, Ritti-Dias RM, Balagopal B, de Oliveira Conceicao RD, et al
    Physical activity levels and hepatic steatosis: a longitudinal follow up study in adults.
    J Gastroenterol Hepatol. 2017 Aug 30. doi: 10.1111/jgh.13965.
    PubMed     Text format     Abstract available
    
    
    
82. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
    Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
    J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
    PubMed     Text format     Abstract available
    
    
    
83. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
    Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
    PubMed     Text format     Abstract available
    
    
    
84. HO CM, Wu CH, Liau JY
    Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
    J Gastroenterol Hepatol. 2017;32:1424.
    PubMed     Text format    
    
    
    
85. MATSUMURA K, Hashimoto D, Umezaki N, Nakagawa S, et al
    Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
    J Gastroenterol Hepatol. 2017;32:1425.
    PubMed     Text format    
    
    
    July 2017
86. DE SANTIS A, Nardelli S, Bassanelli C, Lupo M, et al
    The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
    J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907.
    PubMed     Text format     Abstract available
    
    
    
87. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
    Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
    J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
    PubMed     Text format     Abstract available
    
    
    
88. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
    J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
    PubMed     Text format     Abstract available
    
    
    
89. ZHONG X, Liu H
    Honokiol attenuates Diet-Induced Nonalcoholic Steatohepatitis by regulating macrophage polarization through activating PPARgamma.
    J Gastroenterol Hepatol. 2017 Jul 2. doi: 10.1111/jgh.13853.
    PubMed     Text format     Abstract available
    
    
    
90. COSTA JM, Costa D, Vieira F, Rolanda C, et al
    Hepatobiliary and Pancreatic: Giant hepatomegaly from hepatic hemagiomatosis.
    J Gastroenterol Hepatol. 2017;32:1285.
    PubMed     Text format    
    
    
    
91. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.
    PubMed     Text format    
    
    
    
92. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
    Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
    J Gastroenterol Hepatol. 2017;32:1378-1386.
    PubMed     Text format     Abstract available
    
    
    
93. LOONG TC, Wei JL, Leung JC, Wong GL, et al
    Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2017;32:1363-1369.
    PubMed     Text format     Abstract available
    
    
    June 2017
94. KIM BS, Seo YS, Kim YS, Lee CH, et al
    Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
    PubMed     Text format     Abstract available
    
    
    
95. FUJITA K, Niki T, Nomura T, Oura K, et al
    Serum galectin-9 levels are correlated to liver fibrosis regardless of chronic inflammation or hepatocellular carcinoma complications.
    J Gastroenterol Hepatol. 2017 Jun 15. doi: 10.1111/jgh.13851.
    PubMed     Text format     Abstract available
    
    
    
96. SZKLARUK J, Kaya D, Wei W
    Evaluation of the Added Value of Imaging the Pelvis in Patients with Hepatocellular Cancer.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13847.
    PubMed     Text format     Abstract available
    
    
    
97. KIM BH, Lim YS, Kim EY, Kong HJ, et al
    Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13848.
    PubMed     Text format     Abstract available
    
    
    
98. ZHANG X, Li J, Shen F, Lau WY, et al
    Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
    PubMed     Text format     Abstract available
    
    
    
99. LING QA, Yo J, Gerstenmaier JF, Kemp W, et al
    Hepatobiliary and Pancreatic: Hepatic and mesenteric aneurysms with biloma formation.
    J Gastroenterol Hepatol. 2017;32:1134.
    PubMed     Text format    
    
    
    
100. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
     Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
     J Gastroenterol Hepatol. 2017;32:1240-1249.
     PubMed     Text format     Abstract available
     
     
     May 2017
101. LIU CH, Liu CJ, Hong CM, Su TH, et al
     A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
     J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
     PubMed     Text format     Abstract available
     
     
     
102. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
     Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
     J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
     PubMed     Text format     Abstract available
     
     
     
103. KIM JH, Lim KS, Min YW, Lee H, et al
     Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
     J Gastroenterol Hepatol. 2017;32:1064-1070.
     PubMed     Text format     Abstract available
     
     
     
104. MAIA L, Ferreira JM, Pedroto I
     Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
     J Gastroenterol Hepatol. 2017;32:948.
     PubMed     Text format    
     
     
     
105. JUN DW, Kim SG, Park SH, Jin SY, et al
     External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
     J Gastroenterol Hepatol. 2017;32:1094-1099.
     PubMed     Text format     Abstract available
     
     
     
106. PARKER R, Hodson J, Rowe IAC
     Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
     J Gastroenterol Hepatol. 2017;32:950-956.
     PubMed     Text format     Abstract available
     
     
     
107. RASHID HO, Kim HK, Junjappa R, Kim HR, et al
     Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1alpha and beta-dependent decay and miRNA.
     J Gastroenterol Hepatol. 2017;32:981-991.
     PubMed     Text format     Abstract available
     
     
     April 2017
108. ITO K, Murotani K, Nakade Y, Inoue T, et al
     Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
     J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
     PubMed     Text format     Abstract available
     
     
     
109. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
     Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
     J Gastroenterol Hepatol. 2017;32:738.
     PubMed     Text format    
     
     
     
110. LOURENCO LC, Horta DV, Reis J
     Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
     J Gastroenterol Hepatol. 2017;32:739.
     PubMed     Text format    
     
     
     
111. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
     ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
     J Gastroenterol Hepatol. 2017;32:879-886.
     PubMed     Text format     Abstract available
     
     
     
112. NJEI B, McCarty TR, Laine L
     Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
     J Gastroenterol Hepatol. 2017;32:852-858.
     PubMed     Text format     Abstract available
     
     
     March 2017
113. JIANG T, Du F, Qin N, Lu Q, et al
     Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
     J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
     PubMed     Text format     Abstract available
     
     
     
114. KUO YH, Wang JH, Hung CH, Rau KM, et al
     The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib.
     J Gastroenterol Hepatol. 2017 Mar 11. doi: 10.1111/jgh.13783.
     PubMed     Text format     Abstract available
     
     
     
115. HSIEH YC, Lee KC, Chen PH, Su CW, et al
     Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
     J Gastroenterol Hepatol. 2017 Mar 8. doi: 10.1111/jgh.13777.
     PubMed     Text format     Abstract available
     
     
     
116. SATO M, Tateishi R, Yasunaga H, Matsui H, et al
     Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey.
     J Gastroenterol Hepatol. 2017 Mar 7. doi: 10.1111/jgh.13780.
     PubMed     Text format     Abstract available
     
     
     
117. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
     Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
     J Gastroenterol Hepatol. 2017;32:547.
     PubMed     Text format    
     
     
     
118. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
     Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
     J Gastroenterol Hepatol. 2017;32:546.
     PubMed     Text format    
     
     
     
119. ZENG XQ, Ma LL, Tseng YJ, Chen J, et al
     Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: A randomized pilot study.
     J Gastroenterol Hepatol. 2017;32:631-638.
     PubMed     Text format     Abstract available
     
     
     February 2017
120. KIRSTEIN MM, Schweitzer N, Winter T, Lappas K, et al
     Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma -experience from a referral center.
     J Gastroenterol Hepatol. 2017 Feb 10. doi: 10.1111/jgh.13761.
     PubMed     Text format     Abstract available
     
     
     
121. LYON KC, Likar E, Martello JL, Regier M, et al
     Retrospective Cross-Sectional Pilot Study of Rifaximin Dosing for the Prevention of Recurrent Hepatic Encephalopathy.
     J Gastroenterol Hepatol. 2017 Feb 8. doi: 10.1111/jgh.13759.
     PubMed     Text format     Abstract available
     
     
     
122. SAWAHARA H, Shiraha H, Uchida D, Kato H, et al
     Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2017 Feb 6. doi: 10.1111/jgh.13757.
     PubMed     Text format     Abstract available
     
     
     
123. YOOPRASERT S, Thanapirom K, Treeprasertsuk S, Kullavanijaya P, et al
     Hepatobiliary and Pancreatic: Epstein-Barr virus-associated smooth muscle tumors: Unusual cause of hepatic mass in AIDS patient.
     J Gastroenterol Hepatol. 2017;32:293.
     PubMed     Text format    
     
     
     
124. CHUNG SM, Kim KH, Kim KO, Kim TN, et al
     Hepatobiliary and Pancreatic: Hepatic portal vein gas accompanied by acute enterocolitis improved with non-surgical treatment.
     J Gastroenterol Hepatol. 2017;32:294.
     PubMed     Text format    
     
     
     
125. ROBERTSON M, Watanabe M
     JGH OPEN: A new open access journal for gastroenterology and hepatology.
     J Gastroenterol Hepatol. 2017;32:289.
     PubMed     Text format    
     
     
     
126. CHONG CC, Wong GL, Chan AW, Wong VW, et al
     Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study.
     J Gastroenterol Hepatol. 2017;32:506-514.
     PubMed     Text format     Abstract available
     
     
     
127. SHI KQ, Cai YJ, Lin Z, Dong JZ, et al
     Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
     J Gastroenterol Hepatol. 2017;32:497-505.
     PubMed     Text format     Abstract available
     
     
     January 2017
128. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
     Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
     J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
     PubMed     Text format     Abstract available
     
     
     
129. ZHOU D, Pan Q, Liu XL, Yang RX, et al
     Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
     J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13742.
     PubMed     Text format     Abstract available
     
     
     
130. POLLOCK G, Minuk GY
     Diagnostic Considerations for Cholestatic Liver Disease.
     J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
     PubMed     Text format     Abstract available
     
     
     
131. XUE R, Feng J, Meng Q, Lv F, et al
     The Significance of Glypican-3 Expression Profiling in the Tumor Cellular Origin Theoretical System for Hepatocellular Carcinoma Progression.
     J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13736.
     PubMed     Text format     Abstract available
     
     
     
132. LEE SJ, Kim SU, Kim MD, Kim YH, et al
     Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
     J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13729.
     PubMed     Text format     Abstract available
     
     
     
133. SI T, Chen Y, Ma D, Gong X, et al
     Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta-analysis.
     J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13727.
     PubMed     Text format     Abstract available
     
     
     
134. WANG Y, Huang W, Li R, Yun Z, et al
     Systematic Quantitation of Histologic Patterns Shows Accuracy in Reflecting Cirrhotic Remodeling.
     J Gastroenterol Hepatol. 2017 Jan 9. doi: 10.1111/jgh.13722.
     PubMed     Text format     Abstract available
     
     
     
135. REY S, Quintavalle C, Burmeister K, Calabrese D, et al
     LIVER DAMAGE AND SENESCENCE INCREASES IN PATIENTS DEVELOPING HEPATOCELLULAR CARCINOMA.
     J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13717.
     PubMed     Text format     Abstract available
     
     
     
136. BHAMIDIMARRI KR, Lanza DC, Kashikar ND
     Hepatobiliary and Pancreatic: A unique case of HPV related metastatic Schneiderian carcinoma presenting as polycystic liver disease.
     J Gastroenterol Hepatol. 2017;32:10.
     PubMed     Text format    
     
     
     
137. SANO I, Kuwatani M, Sugiura R, Kato S, et al
     Hepatobiliary and Pancreatic: A rare case of a well-differentiated neuroendocrine tumor in the bile duct with spontaneous regression diagnosed by EUS-FNA.
     J Gastroenterol Hepatol. 2017;32:11.
     PubMed     Text format    
     
     
     
138. RATHOD K, Deshmukh H, Shukla A, Popat B, et al
     Endovascular treatment of Budd-Chiari syndrome: Single center experience.
     J Gastroenterol Hepatol. 2017;32:237-243.
     PubMed     Text format     Abstract available
     
     
     
139. CHOI HJ, Moon JH, Kim HK, Lee YN, et al
     KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
     J Gastroenterol Hepatol. 2017;32:154-162.
     PubMed     Text format     Abstract available
     
     
     December 2016
140. BEKKI Y, Yoshizumi T, Shimoda S, Itoh S, et al
     Hepatic stellate cells secrete WFA+ -M2BP; its role in biological interactions with Kupffer cells.
     J Gastroenterol Hepatol. 2016 Dec 22. doi: 10.1111/jgh.13708.
     PubMed     Text format     Abstract available
     
     
     
141. WANG C, Li G, Li J, Li J, et al
     Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Dec 19. doi: 10.1111/jgh.13680.
     PubMed     Text format     Abstract available
     
     
     
142. ZHAO Q, Zhang GL, Zhu X, Su D, et al
     The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
     J Gastroenterol Hepatol. 2016 Dec 16. doi: 10.1111/jgh.13678.
     PubMed     Text format     Abstract available
     
     
     
143. HUANG TS, Lin CL, Shyu YC, Yeh CT, et al
     Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: a population-based cohort study.
     J Gastroenterol Hepatol. 2016 Dec 8. doi: 10.1111/jgh.13670.
     PubMed     Text format     Abstract available
     
     
     
144. RANA SS, Sharma R, Sharma V, Dhalaria L, et al
     Hepatobiliary and Pancreatic: Unusual space occupying lesion of liver.
     J Gastroenterol Hepatol. 2016;31:1916.
     PubMed     Text format    
     
     
     
145. CHETCUTI ZAMMIT S, Chircop A, Cortis K, Pullicino E, et al
     Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: A great mimicker of liver cirrhosis.
     J Gastroenterol Hepatol. 2016;31:1917.
     PubMed     Text format    
     
     
     November 2016
146. SHARMA BC, Singh J, Srivastava S, Sangam A, et al
     A Randomized Controlled Trial Comparing Lactulose Plus Albumin versus Lactulose alone for Treatment of Hepatic Encephalopathy.
     J Gastroenterol Hepatol. 2016 Nov 25. doi: 10.1111/jgh.13666.
     PubMed     Text format     Abstract available
     
     
     
147. PARK JH, Lee DH, Park MS, Jung YS, et al
     CCR5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation.
     J Gastroenterol Hepatol. 2016 Nov 17. doi: 10.1111/jgh.13657.
     PubMed     Text format     Abstract available
     
     
     
148. KIM JH, Sinn DH, Gwak GY, Kang W, et al
     Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients.
     J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13647.
     PubMed     Text format     Abstract available
     
     
     
149. LEE YR, Park SY, Kim SU, Jang SY, et al
     Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
     J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13644.
     PubMed     Text format     Abstract available
     
     
     
150. BUSK TM, Moller S, Pedersen EB, Gerbes A, et al
     Aquaporin-2 Excretion in Hospitalized Patients with Cirrhosis: Relation to Development of Renal Insufficiency and Mortality.
     J Gastroenterol Hepatol. 2016 Nov 7. doi: 10.1111/jgh.13641.
     PubMed     Text format     Abstract available
     
     
     
151. SUN H, Song J, Weng C, Xu J, et al
     Decreased expression of the macrophage scavenger receptor MARCO is associated with tumour progression and poor prognosis in human hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Nov 2. doi: 10.1111/jgh.13633.
     PubMed     Text format     Abstract available
     
     
     
152. HU HJ, Jing QY, Cheng NS, Li FY, et al
     Hepatobiliary and Pancreatic: A hepatic mass involving diaphragm: A real malignancy?
     J Gastroenterol Hepatol. 2016;31:1801.
     PubMed     Text format    
     
     
     October 2016
153. LEE EC, Kim SH, Park H, Lee SD, et al
     Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Consecutive Cohort of 1002 Patients.
     J Gastroenterol Hepatol. 2016 Oct 31. doi: 10.1111/jgh.13632.
     PubMed     Text format     Abstract available
     
     
     
154. INOUE M, Ogasawara S, Chiba T, Ooka Y, et al
     Presence of non-hypervascular hypointense nodules on Gd-EOB-DTPA enhanced MRI in patients with hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Oct 27. doi: 10.1111/jgh.13622.
     PubMed     Text format     Abstract available
     
     
     
155. WARNE CD, Zaloumis SG, Bertalli NA, Delatycki MB, et al
     HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: a genotype-stratified cohort study of hemochromatosis in Australian women.
     J Gastroenterol Hepatol. 2016 Oct 26. doi: 10.1111/jgh.13621.
     PubMed     Text format     Abstract available
     
     
     
156. AHN JM, Kim CH, Um SH, Kim KM, et al
     A validation Study Associating Glutaminase Promoter Variations with Hepatic Encephalopathy in East Asian Populations.
     J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13618.
     PubMed     Text format     Abstract available
     
     
     
157. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
     Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
     J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
     PubMed     Text format     Abstract available
     
     
     
158. 
     Hepatology Clinical.
     J Gastroenterol Hepatol. 2016;31 Suppl 2:89-120.
     PubMed     Text format    
     
     
     September 2016
159. ZHAO H, Chen C, Gu S, Yan X, et al
     Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
     J Gastroenterol Hepatol. 2016 Sep 26. doi: 10.1111/jgh.13603.
     PubMed     Text format     Abstract available
     
     
     
160. LIU P, Qiu Y, Qian Y, Chen X, et al
     Quality of Meta-analyses in Major Leading Gastroenterology and Hepatology Journals: A Systematic Review.
     J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13591.
     PubMed     Text format     Abstract available
     
     
     
161. NOUSO K, Kariyama K, Nakamura S, Oonishi A, et al
     Application of Radiofrequency Ablation for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.
     J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13586.
     PubMed     Text format     Abstract available
     
     
     August 2016
162. CHAN AW, Wong GL, Chan HY, Tong JH, et al
     Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
     J Gastroenterol Hepatol. 2016 Aug 22. doi: 10.1111/jgh.13536.
     PubMed     Text format     Abstract available
     
     
     
163. CHOI SI, Yu A, Kim BH, Ko EJ, et al
     A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
     J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13532.
     PubMed     Text format     Abstract available
     
     
     
164. HU HT, Yao QJ, Meng YL, Li HL, et al
     Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis.
     J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13529.
     PubMed     Text format     Abstract available
     
     
     
165. MORIO K, Imamura M, Kawakami Y, Morio R, et al
     Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients.
     J Gastroenterol Hepatol. 2016 Aug 11. doi: 10.1111/jgh.13511.
     PubMed     Text format     Abstract available
     
     
     
166. LEE YK, Jung KS, Kim DY, Choi JY, et al
     Tumor size might not distinguish outcomes between conventional and drug-eluting chemoembolization for hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Aug 9. doi: 10.1111/jgh.13501.
     PubMed     Text format     Abstract available
     
     
     July 2016
167. PARK TY, Lee SK, Nam K, Oh D, et al
     Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
     J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
     PubMed     Text format     Abstract available
     
     
     
168. RUDNICKA A, Woziwodzka A, Wroblewska A, Rybicka M, et al
     Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.
     J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13495.
     PubMed     Text format     Abstract available
     
     
     
169. HURRY PK, Poulsen JH, Bendtsen F, Moller S, et al
     Neutrophil gelatinase associated lipocalin and Cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
     J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13492.
     PubMed     Text format     Abstract available
     
     
     
170. LEBRETON A, Sinegre T, Pereira B, Lamblin G, et al
     Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
     J Gastroenterol Hepatol. 2016 Jul 15. doi: 10.1111/jgh.13493.
     PubMed     Text format     Abstract available
     
     
     June 2016
171. LIANG XE, Zhong C, Huang L, Yang S, et al
     Stepwise Application of Transient Elastography and Routine Biomarkers Optimizes Hepatitis B Cirrhosis Detection.
     J Gastroenterol Hepatol. 2016 Jun 26. doi: 10.1111/jgh.13475.
     PubMed     Text format     Abstract available
     
     
     
172. CHAN AW, Chong CC, Mo FK, Wong J, et al
     Incorporating Albumin-Bilirubin grade into the Cancer of the Liver Italian Program system for hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Jun 2. doi: 10.1111/jgh.13457.
     PubMed     Text format     Abstract available
     
     
     May 2016
173. TSAI WL, Yeh PH, Tsai CY, Ting CT, et al
     Efficient Programming of Human Mesenchymal Stem Cell Derived Hepatocytes by Epigenetic Regulations.
     J Gastroenterol Hepatol. 2016 May 24. doi: 10.1111/jgh.13451.
     PubMed     Text format     Abstract available
     
     
     
174. NOVEIRY BB, Hirbod-Mobarakeh A, Khalili N, Hourshad N, et al
     Specific immunotherapy in Hepatocellular cancer: a Systematic Review.
     J Gastroenterol Hepatol. 2016 May 21. doi: 10.1111/jgh.13449.
     PubMed     Text format     Abstract available
     
     
     
175. KIM SS, Nam JS, Cho HJ, Won JH, et al
     Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 May 18. doi: 10.1111/jgh.13448.
     PubMed     Text format     Abstract available
     
     
     
176. CHOLONGITAS E, Ioannidou M, Goulis I, Chalevas P, et al
     Comparison of Creatinine and Cystatin Formulae with 51 Chromium-Edta Glomerular Filtration Rate in Patients With Decompensated Cirrhosis.
     J Gastroenterol Hepatol. 2016 May 13. doi: 10.1111/jgh.13446.
     PubMed     Text format     Abstract available
     
     
     
177. PATERNOSTRO R, Reiberger T, Mandorfer M, Schwarzer R, et al
     Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
     J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13439.
     PubMed     Text format     Abstract available
     
     
     
178. PHAN VA, Abu-Assi R, Nguyen N
     Utility of per-oral cholangioscopy in the diagnosis of portal hypertension associated biliopathy.
     J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13442.
     PubMed     Text format    
     
     
     
179. LIU J, Wang J, Jin D, Qi C, et al
     Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic HBV.
     J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13436.
     PubMed     Text format     Abstract available
     
     
     
180. OGURA T, Onda S, Takagi W, Sano T, et al
     Clinical utility of Endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention procedure for high-grade hilar stricture.
     J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13437.
     PubMed     Text format     Abstract available
     
     
     
181. KUTTING F, Schubert J, Franklin J, Bowe A, et al
     Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
     J Gastroenterol Hepatol. 2016 May 3. doi: 10.1111/jgh.13421.
     PubMed     Text format     Abstract available
     
     
     
182. LAI YC, Wu P, Huang CC, Wu CH, et al
     Intra-hepatic arterio-biliary fistula complicated by blunt abdomen trauma demonstrated at angiogram.
     J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13433.
     PubMed     Text format    
     
     
     
183. LUANGSUKRERKA T, Aumpansuba P, Chaiteerakija R
     Liver abscesso-colonic fistula: A rare complication of transarterial chemoembolization for treatment of hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13431.
     PubMed     Text format    
     
     
     April 2016
184. XU X, Li B, Zheng C
     Acute acalculous cholecystitis in systemic lupus erythematosus.
     J Gastroenterol Hepatol. 2016 Apr 30. doi: 10.1111/jgh.13430.
     PubMed     Text format    
     
     
     
185. K YADAV S, Goel A, A Saraswat V, A Thomas M, et al
     Evaluation of Cognitivity, Proinflammatory Cytokines, and Brain MRI in Minimal Hepatic Encephalopathy induced by Cirrhosis and EHPVO.
     J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13427.
     PubMed     Text format     Abstract available
     
     
     
186. ZHANG P, Yang Y, Wen F, Wheeler J, et al
     Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
     J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13425.
     PubMed     Text format     Abstract available
     
     
     
187. CHIEN J, Liu J, Lee MH, Jen CL, et al
     Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
     J Gastroenterol Hepatol. 2016 Apr 26. doi: 10.1111/jgh.13422.
     PubMed     Text format     Abstract available
     
     
     
188. TARDELLI M, Moreno-Viedma V, Zeyda M, Itariu BK, et al
     Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state.
     J Gastroenterol Hepatol. 2016 Apr 15. doi: 10.1111/jgh.13415.
     PubMed     Text format     Abstract available
     
     
     
189. SHEPTULINA A, Shirokova E, Nekrasova T, Blum H, et al
     Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
     J Gastroenterol Hepatol. 2016 Apr 5. doi: 10.1111/jgh.13407.
     PubMed     Text format     Abstract available
     
     
     
190. GUO B, Li D
     A hepatic space-occupying lesion in a woman of childbearing age.
     J Gastroenterol Hepatol. 2016 Apr 4. doi: 10.1111/jgh.13396.
     PubMed     Text format     Abstract available
     
     
     
191. KUROKAWA T, Zheng YW, Ohkohchi N
     Novel functions of platelets in the liver.
     J Gastroenterol Hepatol. 2016;31:745-51.
     PubMed     Text format     Abstract available
     
     
     
192. TSENG CM, Chuang HW, Tai CM
     EDUCATION AND IMAGING. Gastrointestinal: Duodenal metastatic epithelioid angiosarcoma.
     J Gastroenterol Hepatol. 2016;31:705.
     PubMed     Text format    
     
     
     
193. DE LEDINGHEN V, Wong GL, Vergniol J, Chan HL, et al
     Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2016;31:848-55.
     PubMed     Text format     Abstract available
     
     
     
194. DONG Y, Wang WP, Mao F, Ji ZB, et al
     Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
     J Gastroenterol Hepatol. 2016;31:822-8.
     PubMed     Text format     Abstract available
     
     
     March 2016
195. WU W, Zhang J, Yang W, Hu B, et al
     The role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
     J Gastroenterol Hepatol. 2016 Mar 31. doi: 10.1111/jgh.13388.
     PubMed     Text format     Abstract available
     
     
     
196. CHAN WK, Wong VW
     Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
     J Gastroenterol Hepatol. 2016 Mar 25. doi: 10.1111/jgh.13381.
     PubMed     Text format    
     
     
     
197. KAO JH, Tung SY, Lee Y, Thongsawat S, et al
     Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
     J Gastroenterol Hepatol. 2016 Mar 19. doi: 10.1111/jgh.13374.
     PubMed     Text format     Abstract available
     
     
     
198. MAAN R, Zaim R, van der Meer AJ, Feld JJ, et al
     Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis.
     J Gastroenterol Hepatol. 2016 Mar 18. doi: 10.1111/jgh.13373.
     PubMed     Text format     Abstract available
     
     
     
199. CHAN AW, Chong CC, Mo FK, Wong J, et al
     Applicability of Albumin-Bilirubin-based Japan Integrated Staging (ALBI-T) score in hepatitis B-associated hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Mar 15. doi: 10.1111/jgh.13339.
     PubMed     Text format     Abstract available
     
     
     
200. KIM JW, Seong J, Park MS, Kim KS, et al
     Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.
     J Gastroenterol Hepatol. 2016 Mar 10. doi: 10.1111/jgh.13334.
     PubMed     Text format     Abstract available
     
     
     
201. HU Y, Zhang H, Li J, Cong X, et al
     Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
     J Gastroenterol Hepatol. 2016;31:676-84.
     PubMed     Text format     Abstract available
     
     
     
202. SINCLAIR M, Grossmann M, Angus PW, Hoermann R, et al
     Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.
     J Gastroenterol Hepatol. 2016;31:661-7.
     PubMed     Text format     Abstract available
     
     
     
203. HEEBOLL S, El-Houri RB, Hellberg YE, Haldrup D, et al
     Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
     J Gastroenterol Hepatol. 2016;31:668-75.
     PubMed     Text format     Abstract available
     
     
     February 2016
204. JIN YJ, Lee SH, Cho SG, Kim JH, et al
     Prediction of Postoperative Liver Failure using Gadoxetic Acid-enhanced Magnetic Resonance Imaging in Patients with Hepatocellular Carcinoma.
     J Gastroenterol Hepatol. 2016 Feb 24. doi: 10.1111/jgh.13327.
     PubMed     Text format     Abstract available
     
     
     
205. KAIDA T, Higashi T, Kitano Y, Yamamura K, et al
     Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma.
     J Gastroenterol Hepatol. 2016 Feb 20. doi: 10.1111/jgh.13325.
     PubMed     Text format    
     
     
     
206. FRIEDRICH K, Smit M, Wannhoff A, Rupp C, et al
     Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
     J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13319.
     PubMed     Text format     Abstract available
     
     
     
207. LIU H, Liu J, Zhang Y, Liao J, et al
     Contrast-enhanced ultrasound and CT perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
     J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13320.
     PubMed     Text format     Abstract available
     
     
     
208. NISHIDA N, Yada N, Hagiwara S, Sakurai T, et al
     Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13318.
     PubMed     Text format     Abstract available
     
     
     
209. ZHANG AY, Lai CL, Poon RT, Huang FY, et al
     Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13316.
     PubMed     Text format     Abstract available
     
     
     
210. PELUCCHI S, Galimberti S, Greni F, Rametta R, et al
     Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis.
     J Gastroenterol Hepatol. 2016 Feb 11. doi: 10.1111/jgh.13315.
     PubMed     Text format     Abstract available
     
     
     
211. SHAO YY, Liu TH, Lee YH, Hsu CH, et al
     Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13312.
     PubMed     Text format     Abstract available
     
     
     
212. HALABI SA, Sawas T, Sadat B, Jandali A, et al
     Early TIPS Versus Endoscopic Therapy for Secondary Prophylaxis After Management of Acute Esophageal Variceal Bleeding in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
     J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13303.
     PubMed     Text format     Abstract available
     
     
     
213. LU C, Wang K, Zhang CZ, Zhou FG, et al
     The outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection.
     J Gastroenterol Hepatol. 2016 Feb 8. doi: 10.1111/jgh.13309.
     PubMed     Text format     Abstract available
     
     
     
214. KIM HY, Chang Y, Park JY, Ahn H, et al
     Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.
     J Gastroenterol Hepatol. 2016;31:427-33.
     PubMed     Text format     Abstract available
     
     
     
215. CHEN RX, Gan YH, Ge NL, Chen Y, et al
     Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
     J Gastroenterol Hepatol. 2016;31:442-9.
     PubMed     Text format     Abstract available
     
     
     
216. SASAKI H, Murakami Y, Uemura K, Hashimoto Y, et al
     EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection.
     J Gastroenterol Hepatol. 2016;31:287.
     PubMed     Text format    
     
     
     January 2016
217. SATO S, Genda T, Ichida T, Murata A, et al
     Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Jan 13. doi: 10.1111/jgh.13295.
     PubMed     Text format     Abstract available
     
     
     
218. CHAN AW, Kumada T, Toyoda H, Tada T, et al
     Integration of albumin-bilirubin (ALBI) score into Barcelona clinic liver cancer (BCLC) system for hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2016 Jan 9. doi: 10.1111/jgh.13291.
     PubMed     Text format     Abstract available
     
     
     
219. CHUA TC, Roseverne LO, Goh AC, Maher R, et al
     Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma.
     J Gastroenterol Hepatol. 2016 Jan 5. doi: 10.1111/jgh.13285.
     PubMed     Text format    
     
     
     
220. EL SEBAY HM, Safan MA, Daoud AA, Tayel SI, et al
     Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
     J Gastroenterol Hepatol. 2016;31:235-40.
     PubMed     Text format     Abstract available
     
     
     
221. KAPIL S, Duseja A, Sharma BK, Singla B, et al
     Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2016;31:213-21.
     PubMed     Text format     Abstract available
     
     
     
222. CHEN JP, Peng B, Tang L, Sun R, et al
     Fetal and infant exposure to the Chinese famine increases the risk of fatty liver disease in Chongqing, China.
     J Gastroenterol Hepatol. 2016;31:200-5.
     PubMed     Text format     Abstract available
     
     
     
223. CARBONE LJ, Angus PW, Yeomans ND
     Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
     J Gastroenterol Hepatol. 2016;31:23-31.
     PubMed     Text format     Abstract available
     
     
     
224. DING PX, Zhang SJ, Li Z, Fu MT, et al
     Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome.
     J Gastroenterol Hepatol. 2016;31:222-8.
     PubMed     Text format     Abstract available
     
     
     December 2015
225. SINGH J, Sharma BC, Maharshi S, Puri V, et al
     Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
     J Gastroenterol Hepatol. 2015 Dec 30. doi: 10.1111/jgh.13283.
     PubMed     Text format     Abstract available
     
     
     
226. CHEN J, Fan X, Zhou L, Gao X, et al
     Treatment with geraniol ameliorates methionine-choline deficient diet-induced nonalcoholic steatohepatitis in rats.
     J Gastroenterol Hepatol. 2015 Dec 22. doi: 10.1111/jgh.13272.
     PubMed     Text format     Abstract available
     
     
     
227. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
     Performance of magnetic resonance elastography in primary sclerosing cholangitis.
     J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
     PubMed     Text format     Abstract available
     
     
     
228. FUNG AC, Chok KS, Lo AW, Lo CM, et al
     Hepatic splenosis - a rare differential in an HBV endemic area.
     J Gastroenterol Hepatol. 2015 Dec 20. doi: 10.1111/jgh.13275.
     PubMed     Text format    
     
     
     
229. VAN DER MEER AJ, Maan R, Veldt BJ, Feld JJ, et al
     Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
     J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13252.
     PubMed     Text format     Abstract available
     
     
     
230. HIRAOKA A, Kumada T, Michitaka K, Toyoda H, et al
     Usefulness of albumin-bilirubin (ALBI) grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13250.
     PubMed     Text format     Abstract available
     
     
     
231. QIN B, Wei T, Wang L, Ma N, et al
     Decreased expression of TIPE2 contributes to the hyper-reactivity of monocyte to TLR ligands in primary biliary cirrhosis.
     J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13251.
     PubMed     Text format     Abstract available
     
     
     
232. GAETANO JN, Micic D, Aronsohn A, Reddy G, et al
     The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
     J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13255.
     PubMed     Text format     Abstract available
     
     
     
233. WANG YB, Zhang JY, Gong JP, Zhang F, et al
     Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
     J Gastroenterol Hepatol. 2015 Dec 5. doi: 10.1111/jgh.13248.
     PubMed     Text format     Abstract available
     
     
     
234. DAITOKU N, Okabe H, Hashimoto D, Chikamoto A, et al
     Hepatobiliary and Pancreatic: Replaced common hepatic artery on left gastric artery: a rare anomaly and implication for pancreaticoduodenectomy.
     J Gastroenterol Hepatol. 2015;30:1695.
     PubMed     Text format    
     
     
     
235. NEPAL P, Kumar D, Ramanathan S, Faki A, et al
     Hepatobiliary and Pancreatic: Gall bladder duplication presenting with gall-stone pancreatitis: Use of hepatobiliary specific MRCP in preoperative evaluation of ductal anatomy.
     J Gastroenterol Hepatol. 2015;30:1694.
     PubMed     Text format    
     
     
     November 2015
236. LAI WJ, Chiu NC, Chau GY
     Hepatobiliary and pancreatic: Unusual enhancing tumor in hepatitis B carrier.
     J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13237.
     PubMed     Text format    
     
     
     
237. GASSIEP I, Clark PJ, McManus DP, Looke DL, et al
     Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic schistosoma mansoni infection and post- praziquantel therapy.
     J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13239.
     PubMed     Text format    
     
     
     
238. MAIWALL R, Kumar S, Sharma MK, Wani Z, et al
     Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
     J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13243.
     PubMed     Text format     Abstract available
     
     
     
239. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
     The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
     J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
     PubMed     Text format     Abstract available
     
     
     
240. GOH GB, Issa D, Lopez R, Dasarathy S, et al
     The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2015 Nov 20. doi: 10.1111/jgh.13235.
     PubMed     Text format     Abstract available
     
     
     
241. NAGAOKI Y, Aikata H, Nakano N, Shinohara F, et al
     Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
     J Gastroenterol Hepatol. 2015 Nov 19. doi: 10.1111/jgh.13236.
     PubMed     Text format     Abstract available
     
     
     
242. POK S, Barn VA, Wong HJ, Blackburn AC, et al
     Testosterone regulation of cyclin E kinase is a key factor determining gender differences in hepatocarcinogenesis.
     J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13232.
     PubMed     Text format     Abstract available
     
     
     
243. HIRAMATSU N, Yamada R, Takehara T
     The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
     J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13229.
     PubMed     Text format     Abstract available
     
     
     
244. KIM Y, Lee EJ, Jang HK, Kim CH, et al
     Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
     J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
     PubMed     Text format     Abstract available
     
     
     October 2015
245. WANG D, Wang Q, Yin J, Dong R, et al
     Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
     J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
     PubMed     Text format     Abstract available
     
     
     June 2015
246. TOMENO W, Kawashima K, Yoneda M, Saito S, et al
     Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy.
     J Gastroenterol Hepatol. 2015;30:1009-14.
     PubMed     Text format     Abstract available
     
     
     
247. LIM S, Han J, Kim GM, Han KH, et al
     Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib.
     J Gastroenterol Hepatol. 2015;30:1024-31.
     PubMed     Text format     Abstract available
     
     
     
248. SEKIMOTO T, Maruyama H, Kondo T, Shimada T, et al
     Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease.
     J Gastroenterol Hepatol. 2015;30:1001-8.
     PubMed     Text format     Abstract available
     
     
     May 2015
249. ZHANG L, You W, Zhang H, Peng R, et al
     PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
     J Gastroenterol Hepatol. 2015;30:821-9.
     PubMed     Text format     Abstract available
     
     
     
250. KIMURA T, Deshpande GA, Urayama KY, Masuda K, et al
     Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
     J Gastroenterol Hepatol. 2015;30:909-17.
     PubMed     Text format     Abstract available
     
     
     
251. KARRAR A, Stepanova M, Alaparthi L, Lingam S, et al
     Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2015;30:900-8.
     PubMed     Text format     Abstract available
     
     
     
252. YANG X, Miao R, Yang H, Chi T, et al
     Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver.
     J Gastroenterol Hepatol. 2015;30:885-90.
     PubMed     Text format     Abstract available
     
     
     April 2015
253. CHENG R, Cooper A, Kench J, Watson G, et al
     Ipilimumab-induced toxicities and the gastroenterologist.
     J Gastroenterol Hepatol. 2015;30:657-66.
     PubMed     Text format     Abstract available
     
     
     
254. YE LC, Wei Y, Zhu DX, Chen T, et al
     Impact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.
     J Gastroenterol Hepatol. 2015;30:674-9.
     PubMed     Text format     Abstract available
     
     
     
255. JIA J, Hou J, Ding H, Chen G, et al
     Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
     J Gastroenterol Hepatol. 2015;30:756-62.
     PubMed     Text format     Abstract available
     
     
     
256. CHOUDHARY NS, Saraf N, Saigal S, Gautam D, et al
     Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians.
     J Gastroenterol Hepatol. 2015;30:763-6.
     PubMed     Text format     Abstract available
     
     
     
257. SHIN JY, Kim MJ, Kim ES, Mo EY, et al
     Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population.
     J Gastroenterol Hepatol. 2015;30:733-41.
     PubMed     Text format     Abstract available
     
     
     February 2015
258. CHANG ML, Hsu CM, Tseng JH, Tsou YK, et al
     Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
     J Gastroenterol Hepatol. 2015;30:329-36.
     PubMed     Text format     Abstract available
     
     
     
259. GAO L, Ge C, Fang T, Zhao F, et al
     ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2015;30:396-404.
     PubMed     Text format     Abstract available
     
     
     
260. SONG CY, Zeng X, Wang Y, Shi J, et al
     Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
     J Gastroenterol Hepatol. 2015;30:405-12.
     PubMed     Text format     Abstract available
     
     
     
261. WANG JH, Kee KM, Lin CY, Hung CH, et al
     Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2015;30:358-63.
     PubMed     Text format     Abstract available
     
     
     
262. SINCLAIR M, Grossmann M, Gow PJ, Angus PW, et al
     Testosterone in men with advanced liver disease: abnormalities and implications.
     J Gastroenterol Hepatol. 2015;30:244-51.
     PubMed     Text format     Abstract available
     
     
     
263. LIN ZY, Wu CC, Chuang YH, Chuang WL, et al
     Clinical utility of a simple primary culture method in hepatocellular carcinoma patients.
     J Gastroenterol Hepatol. 2015;30:352-7.
     PubMed     Text format     Abstract available
     
     
     January 2015
264. DONG R, Zheng S
     Interleukin-8: A critical chemokine in biliary atresia.
     J Gastroenterol Hepatol. 2015 Jan 22. doi: 10.1111/jgh.12900.
     PubMed     Text format     Abstract available
     
     
     August 2014
265. KASHIHARA H, Shimada M, Kurita N, Sato H, et al
     Duodenal-jejunal bypass improves diabetes and liver steatosis via enhanced glucagon-like peptide-1 elicited by bile acids.
     J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12690.
     PubMed     Text format     Abstract available
     
     
     
266. OGASAWARA S, Akiba J, Nakayama M, Nakashima O, et al
     Epithelial cell adhesion molecule-positive human hepatic neoplastic cells can develop combined hepatocellular-cholangiocarcinoma in mice.
     J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12692.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: